Trials / Completed
CompletedNCT03105869
Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Monocentric study. Objective : Determination of the repeatability of fluorocholine PET/CT in prostate cancer
Detailed description
A second PET/CT with fluorocholine is performed within 2 weeks after a first examination performed in patient referred for an initial prostate cancer or a biological suspicion of relapse.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | fluorocholine PET/CT | standard diagnostic PET/CT procedure |
Timeline
- Start date
- 2014-12-16
- Primary completion
- 2016-12-31
- Completion
- 2016-12-31
- First posted
- 2017-04-10
- Last updated
- 2017-06-26
Source: ClinicalTrials.gov record NCT03105869. Inclusion in this directory is not an endorsement.